IFP Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.77K Hold
81
﹤0.01% 3538
2026
Q1
$8.84K Hold
81
﹤0.01% 3208
2025
Q4
$6.57K Sell
81
-1
-1% -$86 ﹤0.01% 3275
2025
Q3
$7.18K Sell
82
-25
-23% -$2.23K ﹤0.01% 3068
2025
Q2
$8.88K Buy
107
+49
+84% +$4.09K ﹤0.01% 2993
2025
Q1
$4.87K Buy
58
+57
+5,700% +$5.3K ﹤0.01% 2850
2024
Q4
$92 Buy
+1
New +$96 ﹤0.01% 4064
2023
Q1
Sell
-249
Closed -$12K 3992
2022
Q4
$12K Sell
249
-45
-15% -$2.11K ﹤0.01% 3267
2022
Q3
$11K Sell
294
-5
-2% -$250 ﹤0.01% 3585
2022
Q2
$11K Hold
299
﹤0.01% 3334
2022
Q1
$11K Buy
+299
New +$13.4K ﹤0.01% 3333
2020
Q1
Sell
-44
Closed -$1.36K 2892
2019
Q4
$2K Buy
+44
New +$1.52K ﹤0.01% 2527
2016
Q1
Sell
-300
Closed -$5K 2949
2015
Q4
$5K Buy
+300
New +$4.34K ﹤0.01% 2966

Other funds holding LMAT

IFP Advisors's LMAT Position: Q2 2026 in Review

IFP Advisors held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 81 shares worth $7.77K. The position accounts for ﹤0.01% of the portfolio, ranked #3538.

IFP Advisors first reported a position in LMAT in Q4 2015 and has held it in 13 quarters since. The position peaked at $12K in Q4 2022. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • IFP Advisors held 81 shares of LeMaitre Vascular worth $7.77K as of Q2 2026.
  • IFP Advisors left its LeMaitre Vascular share count unchanged in Q2 2026.
  • LeMaitre Vascular made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3538 holding.
  • IFP Advisors first reported a position in LeMaitre Vascular in Q4 2015 and has held it in 13 quarters since.
  • IFP Advisors's LeMaitre Vascular position peaked at $12K in Q4 2022.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.